Zai Lab LtdZLABEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Wellington Management Group LLP | 11.87% | 118.2M | ▲ +1.05pp | 2024-11-08 |
| S.S. OR | 9.20% | 91.6M | — | 2024-11-14 |
| OF ABOVE PERSONS | 6.20% | 61.2M | ▲ +4.30pp | 2024-02-09 |
| FMR LLC | 3.51% | 34.7M | — | 2024-02-09 |
Insider Transactions
Net 90d: −$5.36M · buys $32.7K / sells $5.40MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Yajing Chen | Chief Financial Officer | Sell (open market) | 853 | $20.45 | $17.4K |
| 2026-04-06 | Ying Du | Chairperson & CEO | Sell (open market) | 2.7K | $20.45 | $54.2K |
| 2026-04-06 | Edmondson Frazor Titus III | Chief Legal Officer | Sell (open market) | 1.2K | $20.45 | $25.0K |
| 2026-04-06 | Rafael Amado | See Remarks | Sell (open market) | 2.7K | $20.45 | $56.0K |
| 2026-04-06 | Smiley Joshua L | See Remarks | Sell (open market) | 3.0K | $20.45 | $61.7K |
| 2026-04-02 | Smiley Joshua L | See Remarks | Option exercise | 7.1K | — | — |
| 2026-04-02 | Smiley Joshua L | See Remarks | Sell (open market) | 9.6K | $20.39 | $196.0K |
| 2026-04-02 | Yajing Chen | Chief Financial Officer | Option exercise | 2.5K | — | — |
| 2026-04-02 | Yajing Chen | Chief Financial Officer | Sell (open market) | 5.2K | $20.39 | $106.0K |
| 2026-04-02 | Rafael Amado | See Remarks | Option exercise | 5.4K | — | — |
1–10 of 47
Page 1 / 5